Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by pierre013on Nov 23, 2016 4:51pm
208 Views
Post# 25505044

RE:PL is good,,,PL is brilliant

RE:PL is good,,,PL is brilliantI got a lot of shares of PLI and I don't sell them. I'm a shareholder accumulating since 2012. I'm very confident on a long term basis, but PL should be more discreet on future. I was at the last AGM and I heard him answer to a question when a shareholder suggested in his question that revenue will be a lot better for 2016. PL did not refrain it. So people felt that revenue will be good for the rest of the year and it did not happen. Same thing for wound healing, at a conference call he said that wound healing clinical trial should be short because the safety and innocuity has been proven. But on monday, Dr. Moran announced that wound healing trial will be a phase 1 and that safety, innocuity and efficacy will part of it and this trial will be completed by the end of 2017. No phase 2 or 3 in sight. And don't try to tell people things that I did not written.PL is brillant and I admire him, but he opened the door for the last manipulation we just have seen lately. I know one of the financing broker firm and how they play on both sides. Hoping for a deal soon...like PL said on monday, it's more and more pregnant. So if it takes too much time to be done, he will lose some credibility. He didn't have to talk about it.
Bullboard Posts